Literature DB >> 28971575

Disseminated tuberculosis masquerading as a presentation of systemic lupus erythematosus.

Justin C-H Li1,2, Warren Fong1,3,4, Limin Wijaya3,4,5, Ying Y Leung1,3,4.   

Abstract

Tuberculosis (TB) infection is the endemic in Asia-Pacific region. Miliary TB is a disseminated form which may present similarly as autoimmune conditions. Here we describe a 17-year-old girl who had miliary TB with manifestations mimicking new-onset systemic lupus erythematosus (SLE) including oral ulcers, serositis, cytopenia, proteinuria and raised autoantibody titers. Complex associations between SLE and TB are highlighted. High index of clinical suspicion for TB infection is needed upon presentations resembling immune diseases like SLE.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  systemic lupus erythematosus; tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28971575     DOI: 10.1111/1756-185X.13195

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  [Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection].

Authors:  G Tang; L Long; Y X Han; Q Peng; J J Liu; H Shang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

2.  Disseminated tuberculosis with macrophage activation syndrome in a child with lupus nephritis.

Authors:  Mahesh Janarthanan; Tessa Antony; Ram Mohan; Sarala Premkumar; Umapathy Pasupathy
Journal:  Sudan J Paediatr       Date:  2021

3.  Miliary tuberculosis mimicking systemic lupus erythematosus flare.

Authors:  Fatehi Elzein; Ahmed Elzein; Nazik Mohammed; Ramiz Alswailem
Journal:  Respir Med Case Rep       Date:  2018-09-11

4.  Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study.

Authors:  Minxi Lao; Dongying Chen; Xiangni Wu; Haihong Chen; Qian Qiu; Xiuyan Yang; Zhongping Zhan
Journal:  Clin Rheumatol       Date:  2018-09-23       Impact factor: 3.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.